APYX (apyxmedical.com) Short-Term Debt to Capital

Apyx Medical (APYX) relies on patent protection for plasma technologies and specialized surgeon training, which ensures physician brand loyalty. Stringent FDA oversight and lobbying capabilities create significant barriers to entry for competitors. Generator production remains in-house, while the manufacturing of consumables is delegated to reliable partners. The indicator is 0.00. This historical price chart below illustrates the dynamics of the company's share value.

This ratio determines the company's dependence on short-term liabilities by comparing loans with a maturity of up to one year against total equity to assess liquidity risk. Analyzing the historical share of short-term debt in equity is critical for Apyx Medical (APYX), as the balance of borrowed funds must support the expansion of helium plasma technology and physician training without risking a cash crunch.